Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001127602-25-017051
Filing Date
2025-06-09
Accepted
2025-06-09 10:03:46
Documents
1
Period of Report
2025-06-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form3.html 3  
1 PRIMARY DOCUMENT form3.xml 3 15590
  Complete submission text file 0001127602-25-017051.txt   17285
Mailing Address 2445 TECHNOLOGY FOREST BLVD. SUITE 1100 THE WOODLANDS TX 77381
Business Address 2445 TECHNOLOGY FOREST BLVD. SUITE 1100 THE WOODLANDS TX 77381 2818633000
LEXICON PHARMACEUTICALS, INC. (Issuer) CIK: 0001062822 (see all company filings)

EIN.: 760474169 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 2445 TECHNOLOGY FOREST BLVD 11TH FLOOR SPRING TX 77381
Business Address
Gopinathan Suma (Reporting) CIK: 0002071581 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-30111 | Film No.: 251033036